Begin with the health question.

What does “peptide therapy” mean?

The units that build proteins can also form small chains called peptides. [a]

US drug law has no single category covering peptide therapy as of September 2026. [a]

The words “peptide therapy” do not tell you whether a medicine has approval from the US drug regulator, is made by a pharmacy for a patient’s needs, or is another unapproved product. [a]

Start with the exact product. Ask which health concern the product is intended to help.

Approval belongs to a product and a use.

The US Food and Drug Administration, known as FDA, reviews medicines.

Semaglutide products with FDA approval as of September 2026 include Ozempic, which controls blood sugar for adults who have type 2 diabetes, and Wegovy for weight management. [b]

FDA approval applies to those particular products; a pharmacy-made medicine with semaglutide does not gain that approval by using the same ingredient. [b]

Ask which product is proposed, how it is supplied (tablet or injection), and which health problem your care provider is discussing.

A pharmacy can make a medicine for a patient’s needs.

Compounding means preparing medicine around one patient’s needs: a doctor or pharmacist makes it instead of providing a drug company’s finished product. [a]

Compounded drugs lack FDA approval as of September 2026; their quality, benefit, and safety receive no agency review before marketing. [a]

According to FDA, a drug prepared by a pharmacy may address a medical need left unmet by approved products. [a]

Ask which medical need requires this approach for you.

Choose a route for the visit.

A telehealth visit uses a video connection, a phone call, or messages exchanged online. An in-person visit takes place in the same room.

Compare how each route will handle your concern, questions, tests, and follow-up. The visit briefing puts those questions side by side.